Susquehanna International Group
IRWD icon

Susquehanna International Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Susquehanna International Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.17M Buy
1,472,157
+1,023,358
+228% +$4.19M ﹤0.01% 4159
2025
Q4 		$1.51M Buy
448,799
+351,933
+363% +$914K ﹤0.01% 6226
2025
Q3 		$127K Sell
96,866
-169,093
-64% -$175K ﹤0.01% 11409
2025
Q2 		$191K Sell
265,959
-382,308
-59% -$300K ﹤0.01% 11259
2025
Q1 		$953K Buy
648,267
+455,976
+237% +$1.09M ﹤0.01% 7378
2024
Q4 		$852K Buy
192,291
+110,617
+135% +$449K ﹤0.01% 7370
2024
Q3 		$336K Buy
81,674
+9,047
+12% +$48.6K ﹤0.01% 9347
2024
Q2 		$474K Sell
72,627
-218,973
-75% -$1.55M ﹤0.01% 8390
2024
Q1 		$2.54M Buy
291,600
+118,631
+69% +$1.44M ﹤0.01% 4840
2023
Q4 		$1.98M Buy
172,969
+57,250
+49% +$566K ﹤0.01% 5373
2023
Q3 		$1.11M Buy
115,719
+59,347
+105% +$582K ﹤0.01% 6391
2023
Q2 		$600K Sell
56,372
-193,251
-77% -$2.08M ﹤0.01% 7883
2023
Q1 		$2.63M Buy
249,623
+115,695
+86% +$1.3M ﹤0.01% 4587
2022
Q4 		$1.66M Sell
133,928
-146,820
-52% -$1.67M ﹤0.01% 5065
2022
Q3 		$2.91M Buy
280,748
+248,877
+781% +$2.82M ﹤0.01% 4160
2022
Q2 		$367K Sell
31,871
-441,276
-93% -$5.2M ﹤0.01% 9009
2022
Q1 		$5.95M Buy
473,147
+19,652
+4% +$225K ﹤0.01% 3345
2021
Q4 		$5.29M Buy
453,495
+53,961
+14% +$662K ﹤0.01% 3642
2021
Q3 		$5.22M Buy
399,534
+46,532
+13% +$601K ﹤0.01% 3871
2021
Q2 		$4.54M Buy
353,002
+74,603
+27% +$854K ﹤0.01% 4206
2021
Q1 		$3.11M Buy
278,399
+103,359
+59% +$1.09M ﹤0.01% 4875
2020
Q4 		$1.99M Buy
175,040
+93,152
+114% +$1.02M ﹤0.01% 5099
2020
Q3 		$736K Sell
81,888
-97,626
-54% -$970K ﹤0.01% 6855
2020
Q2 		$1.85M Buy
179,514
+68,379
+62% +$700K ﹤0.01% 4643
2020
Q1 		$1.12M Buy
111,135
+88,257
+386% +$1.04M ﹤0.01% 5134
2019
Q4 		$305K Sell
22,878
-76,905
-77% -$848K ﹤0.01% 7978
2019
Q3 		$856K Sell
99,783
-41,436
-29% -$403K ﹤0.01% 6040
2019
Q2 		$1.54M Buy
+141,219
New +$1.58M ﹤0.01% 4694
2018
Q4 		– Sell
-39,576
Closed -$454K – 9419
2018
Q3 		$612K Sell
39,576
-158,122
-80% -$2.5M ﹤0.01% 6163
2018
Q2 		$3.17M Buy
+197,698
New +$2.93M ﹤0.01% 3309
2018
Q1 		– Sell
-15,024
Closed -$187K – 9730
2017
Q4 		$189K Buy
+15,024
New +$196K ﹤0.01% 8322
2017
Q1 		– Sell
-117,059
Closed -$1.6M – 9430
2016
Q4 		$1.5M Buy
+117,059
New +$1.48M ﹤0.01% 4667
2016
Q2 		– Sell
-44,690
Closed -$437K – 8918
2016
Q1 		$409K Sell
44,690
-70,869
-61% -$585K ﹤0.01% 6752
2015
Q4 		$1.12M Sell
115,559
-240,614
-68% -$2.33M ﹤0.01% 5180
2015
Q3 		$3.11M Buy
356,173
+52,366
+17% +$489K ﹤0.01% 3440
2015
Q2 		$3.07M Sell
303,807
-219,566
-42% -$2.55M ﹤0.01% 3803
2015
Q1 		$7.01M Buy
523,373
+376,833
+257% +$4.94M ﹤0.01% 2274
2014
Q4 		$1.88M Buy
146,540
+11,811
+9% +$135K ﹤0.01% 4569
2014
Q3 		$1.46M Buy
134,729
+67,544
+101% +$773K ﹤0.01% 5188
2014
Q2 		$863K Buy
67,185
+21,030
+46% +$229K ﹤0.01% 6355
2014
Q1 		$477K Sell
46,155
-84,044
-65% -$945K ﹤0.01% 6808
2013
Q4 		$1.27M Buy
130,199
+108,842
+510% +$977K ﹤0.01% 5079
2013
Q3 		$212K Buy
+21,357
New +$210K ﹤0.01% 7694

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's IRWD Position: Q1 2026 in Review

Susquehanna International Group increased its Ironwood Pharmaceuticals (IRWD) stake by 228% in Q1 2026, buying an estimated $4.19M and bringing the position to 1,472,157 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Susquehanna International Group first reported a position in IRWD in Q3 2013 and has held it in 43 quarters since. The position peaked at $7.01M in Q1 2015. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Susquehanna International Group held 1,472,157 shares of Ironwood Pharmaceuticals worth $5.17M as of Q1 2026.
  • Susquehanna International Group bought 1,023,358 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $4.19M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4159 holding.
  • Susquehanna International Group first reported a position in Ironwood Pharmaceuticals in Q3 2013 and has held it in 43 quarters since.
  • Susquehanna International Group's Ironwood Pharmaceuticals position peaked at $7.01M in Q1 2015.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.